CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac...
Phase 3
Valencia, Spain and 166 other locations
tomography (OCT) findings indicative of vulnerable plaque, in patients with ST-elevation myocardial infarction (STEMI) and multivessel disease...
Valencia, Spain and 47 other locations
The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with...
Valencia, Spain and 63 other locations
with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation...
Phase 3
Valencia, Spain and 518 other locations
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications o...
Phase 3
Valencia, Spain and 820 other locations
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardio...
Phase 3
Valencia, Spain and 623 other locations
and safety of SGLT2 inhibitors in patients with severe CKD.There are two cardiac sub-studies: the cardiac magnetic resonance imagi...
Phase 3
Valencia, Spain and 90 other locations
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease...
Phase 3
Valencia, Valencia, Spain and 742 other locations
cardiovascular events (MACE) including coronary heart disease (CHD) death, ischemic stroke, myocardial infarction (MI), acute limb...
Phase 3
Valencia, Valenciana, Comunitat, Spain and 673 other locations
The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. ...
Phase 3
Valencia, Spain and 825 other locations
Clinical trials
Research sites
Resources
Legal